Itau Unibanco Holding S.A. Nektar Therapeutics Transaction History

Itau Unibanco Holding S.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $32,511 - $55,266	-3,002 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$13.07 - $18.84 $13,932 - $20,083	1,066 Added 55.06%	3,002 $54,000
Q2 2021 Aug 17, 2021	BUY	$16.52 - $20.4 $31,982 - $39,494	1,936 New	1,936 $33,000
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $27,772 - $40,460	-1,750 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$31.0 - $36.3 $43,307 - $50,711	-1,397 Reduced 44.39%	1,750 $62,000

Q4 2018 Feb 13, 2019	BUY	$30.43 - $56.65 $15,975 - $29,741	525 Added 20.02%	3,147 $102,000
Q3 2018 Nov 13, 2018	BUY	$46.46 - $68.49 $121,818 - $179,580	2,622 New	2,622 $160,000
Q2 2018 Aug 13, 2018	SELL	$46.25 - $104.45 $7,492 - $16,920	-162 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$57.4 - $108.44 $9,298 - $17,567	162 New	162 $17,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.